Sex-dimorphic effects of glucose transporter-2 gene knockdown on hypothalamic primary astrocyte phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) cascade protein expression and phosphorylation

被引:0
|
作者
Pasula, Madhu Babu [1 ]
Sapkota, Subash [1 ]
Sylvester, Paul W. [1 ]
Briski, Karen P. [1 ]
机构
[1] Univ Louisiana Monroe, Coll Pharm, Sch Basic Pharmaceut & Toxicol Sci, Monroe, LA 71201 USA
关键词
GLUT2; Glucoprivation; PI3K; Akt; mTOR; ENERGY; HOMEOSTASIS; PATHWAY; 3-KINASES; NUTRIENT; GLUT2; AKT;
D O I
10.1016/j.mce.2024.112341
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glucose transporter-2 (GLUT2), a unique high capacity/low affinity, highly efficient membrane transporter and sensor, regulates hypothalamic astrocyte glucose phosphorylation and glycogen metabolism. The phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway participates in glucose homeostasis, but its sensitivity to glucose-sensory cues is unknown. Current research used a hypothalamic astrocyte primary culture model to investigate whether glucoprivation causes PI3K/Akt/mTOR pathway activation in one or both sexes by GLUT2-dependent mechanisms. Glucoprivation did not alter astrocyte PI3K levels, yet up-regulated both phosphorylated derivatives in female and down-regulated male p60 phosphoprotein expression. GLUT2 siRNA pretreatment diminished glucoprivic patterns of PI3K and phospho-PI3K expression in each sex. Astrocyte Akt and phospho-Akt/Thr308 proteins exhibited divergent, sex-contingent responses to GLUT2 gene knockdown or glucoprivation. GLUT2 siRNA pretreatment exacerbated glucoprivic-associated Akt diminution in the female, and either amplified (male) or reversed (female) glucoprivic regulation of phospho-Akt/Thr308 expression. GLUT2 gene silencing down- (male) or up-(female) regulated mTOR protein, and phospho-mTOR protein in male. Male astrocyte mTOR and phospho-mTOR profile were refractory to glucoprivation, but glucose-deprived females showed GLUT2-independent mTOR inhibition and GLUT2-dependent phospho-mTOR up-augmentation. Results identify a larger number of glucoprivic-sensitive PI3K/Akt/mTOR pathway proteins in female versus male astrocytes, and document divergent responses of common glucose-sensitive targets. GLUT2 stimulates phosphoPI3K protein expression in each sex, but imposes differential control of PI3K, Akt, phospho-Akt/Thr308, mTOR, and phospho-mTOR profiles in male versus female. Data implicate GLUT2 as a driver of distinctive pathway protein responses to glucoprivation in female, but not male.
引用
收藏
页数:10
相关论文
共 39 条
  • [21] A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways
    Gomez, Oscar
    Sanchez-Rodriguez, Maria A.
    Ortega-Gutierrez, Silvia
    Vazquez-Villa, Henar
    Guaza, Carmen
    Molina-Holgado, Francisco
    Molina-Holgado, Eduardo
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 (02) : 309 - 317
  • [22] Practical treatment strategies and novel therapies in the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway in hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative (HRD/HER2L) advanced breast cancer
    Fanucci, K.
    Giordano, A.
    Erick, T.
    Tolaney, S. M.
    Sammons, S.
    ESMO OPEN, 2024, 9 (12)
  • [23] Role of phosphoinositide 3-kinase/ protein kinase B/ phosphatase and tensin homologue (PI3K/AKT/PTEN) pathway inhibitors during in vitro maturation of mammalian oocytes on in vitro embryo production: A systematic review
    Alcaraz, Leticia Pereira
    Prellwitz, Lucia
    Alves, Gutemberg
    Souza-Fabjan, Joanna Maria Gonsalves
    Dias, Angelo Jose Burla
    THERIOGENOLOGY, 2022, 189 : 42 - 52
  • [24] Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells
    Huang, Jinling
    Gao, Likun
    Li, Bingshu
    Liu, Cheng
    Hong, Shasha
    Min, Lie
    Hong, Li
    MEDICAL SCIENCE MONITOR, 2019, 25 : 4250 - 4263
  • [25] Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma
    Makinoshima, Hideki
    Takita, Masahiro
    Saruwatari, Koichi
    Umemura, Shigeki
    Obata, Yuuki
    Ishii, Genichiro
    Matsumoto, Shingo
    Sugiyama, Eri
    Ochiai, Atsushi
    Abe, Ryo
    Goto, Koichi
    Esumi, Hiroyasu
    Tsuchihara, Katsuya
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (28) : 17495 - 17504
  • [26] Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts
    Cao, X
    Kambe, F
    Moeller, LC
    Refetoff, S
    Seo, H
    MOLECULAR ENDOCRINOLOGY, 2005, 19 (01) : 102 - 112
  • [27] Dexmedetomidine promotes cell proliferation and inhibits cell apoptosis by regulating LINC00982 and activating the phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) signaling in hypoxia/reoxygenation-induced H9c2 cells
    Wang, Tao
    Li, Zhen
    Xia, Shuyun
    Xu, Zhixin
    Chen, Xiaofang
    Sun, Hu
    BIOENGINEERED, 2022, 13 (04) : 10159 - 10167
  • [28] Effect of Silencing Information Regulator on Islet β Cells in High Glucose Environment Through Regulation of Phosphatidylinositol 3 Kinase (PI3K)/Protein Kinase B (AKT)/Nuclear Factor-κ-Gene Binding Pathway
    Liu, Nali
    Zhu, Beijing
    Wei, Xin
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (08) : 1624 - 1629
  • [29] Glutamine Enhances the Hypoglycemic Effect of Insulin in L6 Cells via Phosphatidylinositol-3-Kinase (PI3K)/Protein Kinase B (AKT)/Glucose Transporter 4 (GLUT4) Signaling Pathway
    Wang, Caijuan
    Deng, Yujiao
    Yue, Yenan
    Chen, Wenting
    Zhang, Yu
    Shi, Guifang
    Wu, Zhongming
    MEDICAL SCIENCE MONITOR, 2018, 24 : 1241 - 1250
  • [30] Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway
    Song, Lili
    Liu, Shikai
    Zhao, Sufen
    BIOENGINEERED, 2022, 13 (04) : 11240 - 11257